REQUEST A DEMO
Total
USD $0.00
Search more companies

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (广州白云山医药集团股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Navigational, Measuring, Electromedical, and Control Instruments Manufacturing | Management of Companies and Enterprises
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Profile Updated: March 01, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, also known as gybys, is a pharmaceutical manufacturing company based in Guangzhou, China. It was founded in 1997 and operates in the manufacturing and industrials, healthcare, and pharmaceutical manufacturing industries. The company has a small workforce of 1-10 employees. Guangzhou Baiyunshan Pharma specializes in the manufacture and sale of Chinese medicine, Western medicine, and medical equipment. They are involved in wholesale, retail, and import of natural drugs and biomedicine. The company's main shareholders include Guingdong City Pharmakist and Technical Co., Ltd. and Guangzhou White Nuclear Pharmaceuticals Group Limited. Their target market includes the health services, health management, pension, and other health industry sectors. They also engage in the wholesale, retail, and export business of western medicines and medical equipment.

Headquarters
No. 45, Shamian North Street, Liwan District, Guangzhou City, Guangdong Province
Guangzhou; Guangdong; Postal Code: 510130

Contact Details: Purchase the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (广州白云山医药集团股份有限公司) report to view the information.

Website: http://www.gybys.com.cn

Basic Information
Total Employees:
Purchase the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (广州白云山医药集团股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (广州白云山医药集团股份有限公司) report to view the information.
Registered Capital:
Purchase the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (广州白云山医药集团股份有限公司) report to view the information.
Financial Auditors:
Purchase the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (广州白云山医药集团股份有限公司) report to view the information.
Incorporation Date:
September 01, 1997
Key Executives
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Executive Director
Ownership Details
Purchase this report to view the information.
45.04%
Purchase this report to view the information.
13.52%
Purchase this report to view the information.
4.16%
Purchase this report to view the information.
2.91%
Purchase this report to view the information.
1.23%
Subsidiaries
Baiyunshan Welling Pharmaceutical Co., Ltd.
100%
Gansu Guangyao Baiyunshan Traditional Chinese Medicine Technology Co., Ltd.
100%
Guangyao (Zhuhai Hengqin) Pharmaceutical Industrial Park Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (广州白云山医药集团股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
4.31%
Total operating revenue
4.43%
Operating Profit/Loss (EBIT)
2.85%
Net Profit/Loss for the Period
3.3%
Total Assets
4.94%
Total Equity
5.07%
Operating Profit Margin (ROS)
-0.1%
Net Profit Margin
-0.05%
Return on Equity (ROE)
-0.14%
Debt/Equity
2.15%
Quick Ratio
0.16%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?